These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 32734208)

  • 1. Continuous Glucose Monitoring and Glycemic Control in Patients With Type 2 Diabetes Mellitus and CKD.
    Presswala L; Hong S; Harris Y; Romao I; Zhang M; Jhaveri KD; Sakhiya V; Fishbane S
    Kidney Med; 2019; 1(5):281-287. PubMed ID: 32734208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How does CKD affect HbA1c?
    Bloomgarden Z; Handelsman Y
    J Diabetes; 2018 Apr; 10(4):270. PubMed ID: 29124865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4.
    Chen HS; Wu TE; Lin HD; Jap TS; Hsiao LC; Lee SH; Lin SH
    Am J Kidney Dis; 2010 May; 55(5):867-74. PubMed ID: 20202728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Accuracy of Hemoglobin A1c and Fructosamine Evaluated by Long-Term Continuous Glucose Monitoring in Patients with Type 2 Diabetes Undergoing Hemodialysis.
    Bomholt T; Rix M; Almdal T; Knop FK; Rosthøj S; Heinrich NS; Jørgensen MB; Larsson A; Hilsted L; Feldt-Rasmussen B; Hornum M
    Blood Purif; 2022; 51(7):608-616. PubMed ID: 34583354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemoglobin A1c and Fructosamine Evaluated in Patients with Type 2 Diabetes Receiving Peritoneal Dialysis Using Long-Term Continuous Glucose Monitoring.
    Bomholt T; Feldt-Rasmussen B; Butt R; Borg R; Sarwary MH; Elung-Jensen T; Almdal T; Knop FK; Nørgaard K; Ranjan AG; Larsson A; Rix M; Hornum M
    Nephron; 2022; 146(2):146-152. PubMed ID: 34731864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous Glucose Monitoring Metrics in the Assessment of Glycemia in Moderate-to-Advanced CKD in Diabetes.
    Ling J; Ng JKCC; Lau ESH; Ma RCW; Kong APS; Luk AOY; Kwok JSS; Szeto CC; Chan JCN; Chow E
    Kidney Int Rep; 2022 Jun; 7(6):1354-1363. PubMed ID: 35685309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus in chronic kidney disease: Biomarkers beyond HbA1c to estimate glycemic control and diabetes-dependent morbidity and mortality.
    Copur S; Onal EM; Afsar B; Ortiz A; van Raalte DH; Cherney DZ; Rossing P; Kanbay M
    J Diabetes Complications; 2020 Nov; 34(11):107707. PubMed ID: 32861562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study).
    Toyoshima MTK; Cukier P; Damascena AS; Batista RL; de Azevedo Correa F; Zanatta Kawahara E; Minanni CA; Hoff AO; Nery M
    Clinics (Sao Paulo); 2023; 78():100240. PubMed ID: 37390617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordance Between Glycated Hemoglobin A1c and the Glucose Management Indicator in People With Diabetes and Chronic Kidney Disease.
    Oriot P; Viry C; Vandelaer A; Grigioni S; Roy M; Philips JC; Prévost G
    J Diabetes Sci Technol; 2023 Nov; 17(6):1553-1562. PubMed ID: 35466719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary care diabetes assessment when HbA1c and other measures of glycemia disagree.
    Friedman JG; Smith EP; Awasty SS; Behan M; Genco MT; Hempel H; Jafri S; Jandarov R; Nagaraj T; Franco RS; Cohen RM
    Prim Care Diabetes; 2024 Apr; 18(2):151-156. PubMed ID: 38172007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum fructosamine a better indicator than glycated hemoglobin for monitoring gestational diabetes mellitus.
    Ayyappan S; Philips S; Kumar CK; Vaithiyanandane V; Sasikala C
    J Pharm Bioallied Sci; 2015 Apr; 7(Suppl 1):S32-4. PubMed ID: 26015742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring HIV-infected Patients with Diabetes: Hemoglobin A1c, Fructosamine, or Glucose?
    Kim SY; Friedmann P; Seth A; Fleckman AM
    Clin Med Insights Endocrinol Diabetes; 2014; 7():41-5. PubMed ID: 25520565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Assessment of the Utility of Serum Fructosamine in the Diagnosis and Monitoring of Diabetes Mellitus.
    John J; Sakarde A; Chafle J; Amle D; Jose J; Sakhare V; Rathod BD
    Cureus; 2023 Jan; 15(1):e33549. PubMed ID: 36779109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Prospective Observational Study.
    Hong S; Presswala L; Harris YT; Romao I; Ross DW; Andrade Paz H; Zhang M; Jhaveri KD; Sakhiya V; Fishbane S
    Kidney360; 2020 Sep; 1(9):897-903. PubMed ID: 35369557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation Gap in Patients with Diabetes with Chronic Kidney Disease and Healthy Participants: A Comparative Study.
    Neelofar K; Ahmad J
    Indian J Endocrinol Metab; 2017; 21(3):410-414. PubMed ID: 28553596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine).
    Edelman SV; Callahan P; Deeb LC
    Diabetes Technol Ther; 2000; 2(2):233-8. PubMed ID: 11469264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated albumin is a more accurate glycaemic indicator than haemoglobin A
    Kim IY; Kim MJ; Lee DW; Lee SB; Rhee H; Song SH; Seong EY; Kwak IS
    Nephrology (Carlton); 2015 Oct; 20(10):715-720. PubMed ID: 25974106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Alternative Markers of Carbohydrate Metabolism (Fructosamine and 1,5-Anhydroglucitol) with Perioperative Characteristics and In-Hospital Complications of Coronary Artery Bypass Grafting in Patients with Type 2 Diabetes Mellitus, Prediabetes, and Normoglycemia.
    Sumin AN; Bezdenezhnykh NA; Bezdenezhnykh AV; Kuzmina AA; Dyleva YA; Barbarash OL
    Diagnostics (Basel); 2023 Mar; 13(5):. PubMed ID: 36900114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative analysis of fructosamine with other risk factors for kidney dysfunction in diabetic patients with or without chronic kidney disease.
    Neelofar K; Ahmad J
    Diabetes Metab Syndr; 2019; 13(1):240-244. PubMed ID: 30641705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary Fructosamine as a Noninvasive Glycemic Biomarker: A Systematic Review.
    Khoury ZH; Illesca P; Sultan AS
    JDR Clin Trans Res; 2021 Oct; 6(4):382-389. PubMed ID: 32881595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.